California congressman tests positive for coronavirus

A California congressman contracted the coronavirus before he could get a second dose of vaccine that would have improved his immunity

Virus-Outbreak-California-Congressman
Virus-Outbreak-California-Congressman

A California congressman contracted the coronavirus before he could get a second dose of vaccine that would have improved his immunity

Democratic Rep. Lou Correa announced Saturday he tested positive upon returning home from Washington, D.C., prompting him to self-quarantine away from his family.

His office said he received the first dose of the Pfizer-BioNTech vaccine on Dec. 19 and has not received the second shot that would have boosted his immunity to about 95%.

“While this diagnosis will prevent me from attending the much-anticipated inauguration of President-elect Joe Biden, I look forward to working with the new administration to unite our country and help the millions of people devastated by the pandemic," Correa said in a statement.

Correa, who represents central Orange County, is the latest House member to report testing positive since dozens of lawmakers huddled together for protection during the Jan. 6 insurrection at the U.S. Capitol. Democratic Rep. Adriano Espaillat of New York said Thursday he contracted the coronavirus even after getting the second dose of the vaccine.

Correa’s office said he was not in the secure room but was outside assisting Capitol Police. He was confronted later last week by a group of Donald Trump supporters, some not wearing masks, at Dulles International Airport in Virginia.

The vaccine is about 52% effective after the first dose, Pfizer-BioNTech said. The efficacy of the vaccine rises to about 95% after the second dose.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in